Sequential C-reactive protein measurements in patients with serious infections: does it help?

Critical Care

Volumn 16, Issue 3, 2012, Pages

  Lobo, Suzana M ^a  

^a HOSPITAL DE BASE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; METHYLPREDNISOLONE; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

ACUTE LIVER FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; BLOODSTREAM INFECTION; CARDIOVASCULAR DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION; LIVER CIRRHOSIS; NOTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; TREATMENT RESPONSE; VENTILATOR ASSOCIATED PNEUMONIA; BACTERIAL INFECTIONS; BLOOD; METABOLISM; PHYSIOLOGIC MONITORING; PROGNOSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOMARKERS; C-REACTIVE PROTEIN; HUMANS; MONITORING, PHYSIOLOGIC; PROGNOSIS; SEPSIS;

EID: 84862755946     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11347     Document Type: Note

References (20)

1. Coelho LM, Salluh JL, Soares M, Bozza F, Verdeal JCR, Castro-Faria-Neto HC, Lapa e Silva JR, Bozza PT, Póvoa P. Patterns of C-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Crit Care 2012, 16:R53. 10.1186/cc11291, 22449513.
2. Bruns AH, Oosterheert JJ, Hak E, Hoepelman AI. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J 2008, 32:726-732. 10.1183/09031936.00003608, 18508833.
3. Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005, 25:804-808. 10.1183/09031936.05.00071704, 15863636.
4. Lisboa T, Seligman R, Diaz E, Rodriguez A, Teixeira PJ, Rello J. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 2008, 36:166-171. 10.1097/01.CCM.0000297886.32564.CF, 18007271.
5. Moreno MS, Nietmann H, Matias CM, Lobo SM. C-reactive protein: a tool in the follow-up of nosocomial pneumonia. J Infect 2010, 61:205-211. 10.1016/j.jinf.2010.06.005, 20600303.
6. Povoa P, Co elho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. Clin Infect Dis 2005, 40:1855-1857. 10.1086/430382, 15909277.
7. Schmit X, Vincent JL. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 2008, 36:213-219. 10.1007/s15010-007-7077-9, 18463788.
8. Póvoa P, Teixeira-Pinto AM, Carneiro AH, . Portuguese Community-Acquired Sepsis Study Group SACiUCI C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care 2011, 15:R169. 10.1186/cc10313, 21762483, Portuguese Community-Acquired Sepsis Study Group SACiUCI.
9. Cox ML, Rudd AG, Gallimore R, Hodkimon TM, Pepys MB. Real-time measurement of serum C-reactive protein in the management of infection in the elderly. Age Ageing 1986, 15:257-266. 10.1093/ageing/15.5.257, 3776747.
10. Ridker PM, Hennekens CH, Buring JE Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843. 10.1056/NEJM200003233421202, 10733371.
11. Cervoni JP, Thévenot T, Weil D, Muel E, Barbot O, Sheppard F, Monnet E, Di Martino V. C-reactive protein predicts short-term mortality in patients with cirrhosis. J Hepatol 2012, 56:1299-1304. 10.1016/j.jhep.2011.12.030, 22314431.
12. Kushner I. C-reactive protein in rheumatology. Arthritis Rheum 1991, 34:1065-1068. 10.1002/art.1780340819, 1859483.
13. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 2009, 27:2217-2224. 10.1200/JCO.2008.19.8440, 19289618.
14. Póvoa P, Souza-Dantas VC, Soares M, Salluh JF. C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Crit Care 2011, 15:R129. 10.1186/cc10242, 3218995, 21595932.
15. Marik PE, Andrews L, Maini B. The incidence of deep venous thrombosis in ICU patients. Chest 1997, 111:661-664. 10.1378/chest.111.3.661, 9118705.
16. Thomas EA, Cobby MJ, Rhys D, Jeans WD, Whicher JT. Liquid crystal thermography and C reactive protein in the detection of deep venous thrombosis. BMJ 1989, 299:951-952. 10.1136/bmj.299.6705.951, 1837818, 2508949.
17. Vincent J, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D, . ABC Investigators Anemia and blood transfusion in critically ill patients. JAMA 2002, 288:1499-1507. 10.1001/jama.288.12.1499, 12243637, ABC Investigators.
18. Cholette JM, Henrichs KF, Alfieris GM, Powers KS, Phipps R, Spinelli SL, Swartz M, Gensini F, Daugherty LE, Nazarian E, Rubenstein JS, Sweeney D, Eaton M, Lerner NB, Blumberg N. Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: results of a prospective, randomized, controlled clinical trial. Pediatr Crit Care Med 2011, 13:290-299.
19. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007, 131:954-963. 10.1378/chest.06-2100, 17426195.
20. Silvestre JP, Coelho LM, Povoa PM. Impact of fulminant hepatic failure in C-reactive protein?. J Crit Care 2010, 25:657.